16-18784832-TAAC-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_001019.5(RPS15A):c.214-12_214-10delGTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,585,296 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 1 hom. )
Consequence
RPS15A
NM_001019.5 intron
NM_001019.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.303
Genes affected
RPS15A (HGNC:10389): (ribosomal protein S15a) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 40S subunit. The protein belongs to the S8P family of ribosomal proteins. It is located in the cytoplasm. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP6
Variant 16-18784832-TAAC-T is Benign according to our data. Variant chr16-18784832-TAAC-T is described in ClinVar as [Likely_benign]. Clinvar id is 2746992.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 24 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152034Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24
AN:
152034
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000220 AC: 51AN: 231822 AF XY: 0.000183 show subpopulations
GnomAD2 exomes
AF:
AC:
51
AN:
231822
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000184 AC: 264AN: 1433144Hom.: 1 AF XY: 0.000174 AC XY: 124AN XY: 713444 show subpopulations
GnomAD4 exome
AF:
AC:
264
AN:
1433144
Hom.:
AF XY:
AC XY:
124
AN XY:
713444
Gnomad4 AFR exome
AF:
AC:
6
AN:
32100
Gnomad4 AMR exome
AF:
AC:
9
AN:
39092
Gnomad4 ASJ exome
AF:
AC:
9
AN:
25300
Gnomad4 EAS exome
AF:
AC:
98
AN:
39406
Gnomad4 SAS exome
AF:
AC:
2
AN:
82030
Gnomad4 FIN exome
AF:
AC:
0
AN:
53232
Gnomad4 NFE exome
AF:
AC:
129
AN:
1096978
Gnomad4 Remaining exome
AF:
AC:
7
AN:
59354
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000158 AC: 24AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74390 show subpopulations
GnomAD4 genome
AF:
AC:
24
AN:
152152
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
74390
Gnomad4 AFR
AF:
AC:
0.0000722613
AN:
0.0000722613
Gnomad4 AMR
AF:
AC:
0.000457875
AN:
0.000457875
Gnomad4 ASJ
AF:
AC:
0.000864553
AN:
0.000864553
Gnomad4 EAS
AF:
AC:
0.000965624
AN:
0.000965624
Gnomad4 SAS
AF:
AC:
0.000207555
AN:
0.000207555
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000735597
AN:
0.0000735597
Gnomad4 OTH
AF:
AC:
0
AN:
0
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at